Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
In the latest session, BrightSpring Health Services Inc (NASDAQ: BTSG) closed at $39.26 up 2.24% from its previous closing price of $38.4. In other words, the price has increased by $2.24 from its previous closing price. On the day, 2.04 million shares were traded. BTSG stock price reached its highest trading level at $39.49 during the session, while it also had its lowest trading level at $38.25.
Ratios:
For a deeper understanding of BrightSpring Health Services Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 50.45 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 22.18. For the most recent quarter (mrq), Quick Ratio is recorded 1.38 and its Current Ratio is at 1.79. In the meantime, Its Debt-to-Equity ratio is 1.48 whereas as Long-Term Debt/Eq ratio is at 1.43.
On December 11, 2025, Stephens started tracking the stock assigning a Overweight rating and target price of $44.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Oct 22 ’25 when KKR Group Partnership L.P. sold 14,745,000 shares for $28.78 per share. The transaction valued at 424,390,590 led to the insider holds 62,351,337 shares of the business.
KKR Phoenix Aggregator L.P. sold 14,745,000 shares of BTSG for $424,390,590 on Oct 22 ’25. The 10% Owner now owns 62,351,337 shares after completing the transaction at $28.78 per share. On Oct 22 ’25, another insider, ROUSSEAU JON B, who serves as the insider of the company, sold 235,000 shares for $28.78 each. As a result, the insider received 6,763,770 and left with 1,131,930 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BTSG now has a Market Capitalization of 7080631296 and an Enterprise Value of 10670142464. As of this moment, BrightSpring’s Price-to-Earnings (P/E) ratio for their current fiscal year is 65.54, and their Forward P/E ratio for the next fiscal year is 29.52. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.68. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.57 while its Price-to-Book (P/B) ratio in mrq is 3.90. Its current Enterprise Value per Revenue stands at 0.802 whereas that against EBITDA is 16.4.
Stock Price History:
The Beta on a monthly basis for BTSG is 2.38, which has changed by 1.2145329 over the last 52 weeks, in comparison to a change of 0.16067612 over the same period for the S&P500. Over the past 52 weeks, BTSG has reached a high of $38.61, while it has fallen to a 52-week low of $15.26. The 50-Day Moving Average of the stock is 12.25%, while the 200-Day Moving Average is calculated to be 52.42%.
Shares Statistics:
For the past three months, BTSG has traded an average of 3.09M shares per day and 1755480 over the past ten days. A total of 180.69M shares are outstanding, with a floating share count of 114.60M. Insiders hold about 36.46% of the company’s shares, while institutions hold 72.64% stake in the company. Shares short for BTSG as of 1765756800 were 8697760 with a Short Ratio of 2.82, compared to 1763078400 on 8670372. Therefore, it implies a Short% of Shares Outstanding of 8697760 and a Short% of Float of 14.729999.
Earnings Estimates
The stock of BrightSpring Health Services Inc (BTSG) is currently drawing attention from 14.0 analysts actively involved in the ongoing evaluation and rating process.The consensus estimate for the next quarter is $0.25, with high estimates of $0.3 and low estimates of $0.2.
Analysts are recommending an EPS of between $1.14 and $0.81 for the fiscal current year, implying an average EPS of $1.03. EPS for the following year is $1.33, with 15.0 analysts recommending between $1.7 and $1.04.
Revenue Estimates
A total of 14 analysts believe the company’s revenue will be $3.38B this quarter.It ranges from a high estimate of $3.55B to a low estimate of $3.29B. As of. The current estimate, BrightSpring Health Services Inc’s year-ago sales were $3.05BFor the next quarter, 14 analysts are estimating revenue of $3.31B. There is a high estimate of $3.59B for the next quarter, whereas the lowest estimate is $3.19B.
A total of 16 analysts have provided revenue estimates for BTSG’s current fiscal year. The highest revenue estimate was $12.91B, while the lowest revenue estimate was $12.65B, resulting in an average revenue estimate of $12.74B. In the same quarter a year ago, actual revenue was $11.27BBased on 16 analysts’ estimates, the company’s revenue will be $14.61B in the next fiscal year. The high estimate is $15.21B and the low estimate is $14.03B.
